Drupal.behaviors.print = function(context) {window.print();window.close();}>
Oxford Immunotec, Lophius Ink Licensing Deals for Development of T-cell-based Assays
January 29, 2013
Oxford Immunotec, Lophius Ink Licensing Deals for Development of T-cell-based Assays
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Castle Bio Licenses IP from Brigham and Women's Hospital for Mesothelioma Test
September 12, 2012 / GenomeWeb Daily News
Seahorse Licenses IP for Cellular Bioenergetics Research
August 21, 2012 / GenomeWeb Daily News
HTG Licenses Merck's Breast Cancer Biomarker Patent Portfolio
July 11, 2012 / GenomeWeb Daily News
PCR Licensing Deal Validates Roche IP; Bolsters Life Tech's Ongoing Push into IVD Market
February 23, 2012 / PCR Insider
TrovaGene Regains Ownership, Patent Control of Transrenal Technology
August 10, 2011 / GenomeWeb Daily News